RecruitingNCT05368467

National Registry and Cohort Study of Pulmonary Vascular Disease


Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

1,000 participants

Start Date

Mar 29, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is a observational、multicenter, prospective cohort study for patients with pulmonary hypertension (PH). The purposes of this study were to evaluate the etiology、clinical characteristics、treatment modalities, and outcomes of patients with PH;also to set up registration system of PH in China, to build a database of Chinese PH, to establish a web-based international standard data acquisition system for PH and a multicenter clinical research platform. The results of the study will provide a basis for the future national health policy for prevention and treatment of PH.


Eligibility

Plain Language Summary

Simplified for easier understanding

This is a national registry and observational study that is tracking patients with pulmonary hypertension (high blood pressure in the lungs) over time. Researchers are collecting data to better understand who gets this disease, how it progresses, and how different treatments affect outcomes. **You may be eligible if...** - You have been diagnosed with pulmonary hypertension (PH), either recently or in the past - Your diagnosis has been confirmed by a test called right heart catheterization, showing elevated pressure in the lung arteries (mean pressure above 20 mmHg) **You may NOT be eligible if...** - Your pulmonary hypertension has not been confirmed by right heart catheterization - Your blood pressure measurements from the catheterization do not meet the required criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

COMBINATION_PRODUCTThe clinical course and disease management

The clinical course and disease management of pulmonary hypertension patients


Locations(13)

Guangdong Provincial Peoples Hospital

Guangzhou, Guangdong, China

Nanjing First Hospital

Nanjing, Jiangsu, China

General Hospital of Tianjin Medical University

Tianjin, Tianjin Municipality, China

Beijing Anzhen Hospital of Capital Medical University

Beijing, China

China-japan Friendship Hospital

Beijing, China

Xiangya Second Hospital, Central South University

Changsha, China

West China Hospital, Sichuan University

Chendu, China

Nanjing Drum Tower Hospital

Nanjing, China

General Hospital of Northen Theater of Command

Shenyang, China

Tongji Hospital, Huazhong University of Science and Technology

Wuhan, China

Zhongnan Hospital of Wuhan University

Wuhan, China

First Affiliated Hospital of Xi'An Jiaotong University

Xi'an, China

First Hospital of Zhengzhou University

Zhengzhou, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05368467


Related Trials